Lyomyxovax
Lyomyxovax
Not authorised
- Shope fibroma virus, Live
Product identification
Medicine name:
Lyomyxovax
Active substance:
- Shope fibroma virus, Live
Target species:
-
Rabbit
Route of administration:
-
Subcutaneous use
Product details
Active substance and strength:
-
Shope fibroma virus, Live2.70/log10 50% tissue culture infectious dose0.50millilitre(s)
Pharmaceutical form:
-
Lyophilisate and solvent for suspension for injection
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI08AD02
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Revoked
Authorised in:
-
Portugal
Package description:
- Available only in Portuguese
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application (Article 8(3) of Directive No 2001/83/EC)
Marketing authorisation holder:
- Boehringer Ingelheim Animal Health Portugal Unipessoal Lda.
Marketing authorisation date:
Manufacturing sites for batch release:
- Boehringer Ingelheim Animal Health Portugal Unipessoal Lda.
Responsible authority:
- Directorate General For Food And Veterinary
Authorisation number:
- UPD 1.6.1-4 JSON NAP Chpt2 C2 Mandatory 51/87DGV
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet